BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ALEXION PHARMACEUTICALS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

ALEXION PHARMACEUTICALS, INC.

via ALEXION PHARMACEUTICALS, INC.

3rd Quarter (July 1 - Sep 30) · 2018Posted Oct 19, 2018Filing document ↗LDA record ↗

Expenses

$323K

self-filed spend

Client

Name: ALEXION PHARMACEUTICALS, INC.
Location: Massachusetts · United States of America

Registrant

Firm: ALEXION PHARMACEUTICALS, INC.
Description: Global biopharmaceutical company
Location: Boston, Massachusetts, United States of America

Lobbying activities

4 issues

Medical/Disease Research/Clinical Labs
ANDUFA
LobbyistsVANESSA PROCTER · LEIGH OWANO
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Intellectual Property Issues
LobbyistsVANESSA PROCTER · LEIGH OWANO
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance Medicare Part D Coinsurance
LobbyistsVANESSA PROCTER · LEIGH OWANO
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Orphan Drug Act Medicaid Reform Drug Pricing Medicare Part D coinsurance DRG Reform
LobbyistsVANESSA PROCTER · LEIGH OWANO
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.